ATE324053T1 - Verfahren und verbindungen zur kontrolle des körpergewichts - Google Patents

Verfahren und verbindungen zur kontrolle des körpergewichts

Info

Publication number
ATE324053T1
ATE324053T1 AT01946620T AT01946620T ATE324053T1 AT E324053 T1 ATE324053 T1 AT E324053T1 AT 01946620 T AT01946620 T AT 01946620T AT 01946620 T AT01946620 T AT 01946620T AT E324053 T1 ATE324053 T1 AT E324053T1
Authority
AT
Austria
Prior art keywords
compounds
methods
body weight
controlling body
controlling
Prior art date
Application number
AT01946620T
Other languages
English (en)
Inventor
Ronald James Jandacek
Gary Robert Kelm
Satinder Singh Bharaj
Jorge Villanueva Penafiel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE324053T1 publication Critical patent/ATE324053T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01946620T 2000-06-26 2001-06-21 Verfahren und verbindungen zur kontrolle des körpergewichts ATE324053T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/603,626 US7025984B1 (en) 2000-06-26 2000-06-26 Compositions and methods for body weight management

Publications (1)

Publication Number Publication Date
ATE324053T1 true ATE324053T1 (de) 2006-05-15

Family

ID=24416242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01946620T ATE324053T1 (de) 2000-06-26 2001-06-21 Verfahren und verbindungen zur kontrolle des körpergewichts

Country Status (17)

Country Link
US (2) US7025984B1 (de)
EP (2) EP1676488A3 (de)
JP (2) JP2004501170A (de)
CN (1) CN100334973C (de)
AR (1) AR029687A1 (de)
AT (1) ATE324053T1 (de)
AU (1) AU2001268644A1 (de)
BR (1) BR0111963A (de)
CA (1) CA2410985C (de)
DE (1) DE60119104T2 (de)
MX (1) MXPA03000048A (de)
NZ (1) NZ522996A (de)
PE (1) PE20020112A1 (de)
PL (1) PL202686B1 (de)
RU (1) RU2301668C2 (de)
WO (1) WO2002000042A2 (de)
ZA (1) ZA200209662B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
AU2003209750A1 (en) * 2002-03-30 2003-10-13 Gunther Beisel Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
US7393552B2 (en) * 2002-04-24 2008-07-01 The Procter & Gamble Company Compositions comprising protein and fatty acid
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US20030203042A1 (en) * 2002-04-24 2003-10-30 Cook Lisa Ann Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
US20030203004A1 (en) * 2002-04-24 2003-10-30 Kelm Gary Robert Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
TW200412942A (en) * 2002-08-06 2004-08-01 Abbott Lab Appetite control method
US20040044079A1 (en) * 2002-09-04 2004-03-04 The Iams Company Methods and compositions for weight control
AU2003294816A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Preparation for reducing the appetite, producing a satiated feeling and/or for weight loss in children
AU2003300531A1 (en) * 2002-12-19 2004-07-29 Gunther Beisel Substance for creating a saturation effect and reducing weight in animals
SE0203886D0 (sv) * 2002-12-27 2002-12-27 Ltp Lipid Technologies Provide Glycerolesterprodukt och dess användning
ES2229935B1 (es) * 2003-10-10 2006-10-01 Universitat De Les Illes Balears Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales.
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
MY142954A (en) * 2005-05-13 2011-01-31 Nisshin Oillio Group Ltd Intermolecular compounds of fatty acid triglycerides
KR100756890B1 (ko) * 2005-08-19 2007-09-07 경희대학교 산학협력단 신경세포 보호활성을 갖는 올레산을 함유하는 조성물
WO2007047596A1 (en) * 2005-10-17 2007-04-26 Hill's Pet Nutrition, Inc. Methods for reducing food intake and decreasing appetite in animals
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
WO2008045739A1 (en) * 2006-10-03 2008-04-17 Myers Michael D Meal replacement compositions and weight control method
US20080220104A1 (en) * 2007-03-08 2008-09-11 Cappello John V Compositions for producing satiety
WO2009109227A1 (de) * 2008-03-05 2009-09-11 Basf Se Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
WO2010028336A2 (en) * 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
KR20180075716A (ko) 2009-04-03 2018-07-04 디에스엠 아이피 어셋츠 비.브이. 포만감 유발 조성물
US10058117B2 (en) * 2009-11-23 2018-08-28 Randall Scott Hickle Dietary health food composition, package and method of use
CN101822662B (zh) * 2010-04-30 2011-06-08 中国人民解放军总医院 9,10-二羟基硬脂酸(dhsa)在制备防治糖尿病药物中的用途
WO2012087486A1 (en) * 2010-12-20 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions for inducing a satiety response
WO2013132092A1 (en) 2012-03-09 2013-09-12 Pensieve International Plc Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
WO2014069227A1 (ja) * 2012-10-29 2014-05-08 国立大学法人京都大学 希少脂肪酸を含む代謝改善剤
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
MA41611A (fr) 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
EP3574899A1 (de) * 2018-05-28 2019-12-04 Université de Bourgogne Ölsäurederivate, pharmazeutische zusammensetzung oder lebensmittelzusammensetzung, die besagte ölsäurederivate enthält, und deren verwendungen
KR102087634B1 (ko) * 2018-10-11 2020-03-11 (주)바이텍 항비만용 조성물
WO2021062383A1 (en) * 2019-09-27 2021-04-01 University Of Virginia Patent Foundation Compositions and methods for preventing and/or reducing weight gain and associated conditions
WO2022040340A1 (en) * 2020-08-20 2022-02-24 Epitracker, Inc. Compositions and methods for treatment of obesity
CN115429815B (zh) * 2021-06-02 2023-12-22 广州帝奇医药技术有限公司 一种长效饱腹组合物、制备方法及用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
US4298601A (en) 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
US3865939A (en) * 1973-02-23 1975-02-11 Procter & Gamble Edible oils having hypocholesterolemic properties
IE47777B1 (en) 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
CH636013A5 (en) * 1978-03-07 1983-05-13 Sandoz Ag More readily absorbable pharmaceutical composition
SE8505569D0 (sv) 1985-11-25 1985-11-25 Aco Laekemedel Ab Enteralt preparat
GB8603171D0 (en) * 1986-02-08 1986-03-12 Howard A N Dietary product
JPH0699321B2 (ja) 1990-01-22 1994-12-07 不二製油株式会社 食欲抑制剤及びこれを含有する食品
US5665384A (en) 1990-04-06 1997-09-09 Rhone-Poulenc Rorer S.A. Oily capsules of ketoprofen
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
DE4133694C2 (de) * 1991-10-11 1993-10-07 Fresenius Ag Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
JP3244586B2 (ja) * 1994-03-23 2002-01-07 キユーピー株式会社 卵白組成物及びそれを利用した食品添加用卵白組成物
JPH08140587A (ja) * 1994-11-18 1996-06-04 Lion Corp ペットフード
EP0827402A2 (de) * 1995-05-17 1998-03-11 Cedars-Sinai Medical Center Fettsäure enthaltende zusammensetzungen zur verbesserung der verdauung und absorption des dünndarms
PT771817E (pt) 1995-10-30 2003-06-30 Oleoyl Estrone Developments S Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de peso
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US5977195A (en) * 1997-08-01 1999-11-02 Huntsman Corporation Expandable thermoplastic polymer particles and method for making same
US6054480A (en) 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
JPH11209279A (ja) 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
MX228618B (es) 1998-05-04 2005-06-21 Conlinco Inc Metodos para utilizar composiciones de acido linoleico conjugado enriquecidas por isomeros.
JP2000014330A (ja) * 1998-07-06 2000-01-18 Emyubaachika Japan Kk エミュオイル加工食品
WO2000058501A2 (en) 1999-03-26 2000-10-05 The Wistar Institute Novel genetic suppressor elements and methods of making the same
GB2355382A (en) 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US6210702B1 (en) * 1999-09-13 2001-04-03 Ratib Al Samman Weight loss composition and method for losing weight
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
US6626644B2 (en) * 2000-10-30 2003-09-30 Ntn Corporation Magnetically levitated pump and controlling circuit
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
US7225486B2 (en) * 2005-01-10 2007-06-05 Jackson Iii Avery M Therapeutic seat cushion

Also Published As

Publication number Publication date
AR029687A1 (es) 2003-07-10
DE60119104D1 (de) 2006-06-01
WO2002000042A3 (en) 2002-04-04
PL202686B1 (pl) 2009-07-31
NZ522996A (en) 2004-10-29
CA2410985C (en) 2008-04-15
DE60119104T2 (de) 2006-11-30
US20050197395A1 (en) 2005-09-08
WO2002000042A2 (en) 2002-01-03
EP1294240A2 (de) 2003-03-26
US8287898B2 (en) 2012-10-16
CN100334973C (zh) 2007-09-05
EP1676488A3 (de) 2013-02-20
JP2009132684A (ja) 2009-06-18
PL360185A1 (en) 2004-09-06
BR0111963A (pt) 2003-05-13
AU2001268644A1 (en) 2002-01-08
CA2410985A1 (en) 2002-01-03
CN1452461A (zh) 2003-10-29
ZA200209662B (en) 2003-10-23
RU2301668C2 (ru) 2007-06-27
MXPA03000048A (es) 2004-07-08
JP2004501170A (ja) 2004-01-15
EP1676488A2 (de) 2006-07-05
US7025984B1 (en) 2006-04-11
EP1294240B1 (de) 2006-04-26
PE20020112A1 (es) 2002-03-14

Similar Documents

Publication Publication Date Title
DE60119104D1 (de) Verfahren und verbindungen zur kontrolle des körpergewichts
DE60205817D1 (de) Verfahren zur Erfassung und Beseitigung des Memory-Effektes
DE60127922D1 (de) Vorrichtung und Verfahren zur Regelung der Fahrzeugbewegung
DE60026661D1 (de) Verfahren zur adaptiven Steuerung des Sperrzustandes
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
DE60001292D1 (de) Siliciumnitridsinterkörper und Verfahren zum Herstellen desselben
DE60116447D1 (de) Verfahren und System zur Verbindungsbehandlung
DE60205623D1 (de) Anhauslieferungsbehälter und anhauslieferungsgepäcksammel/liefersystem und verfahren dafür
DE60039348D1 (de) Verfahren und system zur steuerung des weiterreichens
DE60133263D1 (de) Gerät zur kontrolle des körpergewichtes
DE60143831D1 (de) Massgeschneidertes rohteil und verfahren zur herstellung des teiles
IL174014A0 (en) Methods for the treatment of endometriosis
DE60103889D1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidderivate zur schmerzbekämpfung
DE60235032D1 (de) Rkörpers und verfahren zur herstellung des werkzeugs
EP1278476A4 (de) Systeme und verfahren zur dentalen behandlungsplanung
DE50111701D1 (de) Verfahren zur steuerung des zugriffs
DE50114792D1 (de) Verfahren zur positionsbestimmung und navigationsgerät
DE60321938D1 (de) Zusammensetzung zur schleimvermeidung und verfahren zur schleimvermeidung
DE60009228D1 (de) Verfahren und Gerät zur arithmetischen Steurung
DE50214806D1 (de) Verfahren und vorrichtung zur abgasnachbehandlung
DE60032808D1 (de) Verfahren und system zur optimalisierung des gebrauchs der funkverbindung
DE602004030507D1 (de) Zahnärtzlicher Artikel und Verfahren für Oberflächenmodifikation des zahnärtzlichen Artikels
DE60111520D1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung
EP1385947A4 (de) Zusammensetzungen und verfahren zur blutungskontrolle
DE60109032D1 (de) Chinolinyl-piperidin-4-yliden-methyl-benzamid-derivate zur schmerzbekämpfung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties